StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) bonds

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Calidi Biotherapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2024

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Calidi Biotherapeutics's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Bridge Loan Payable–$200.00K$223.00K
Promissory Note–$600.00K$645.00K
Term Notes Payable–$2.20M$2.95M
Two Thousand Twenty Four Bridge Loan12.00%–$200.00K
Two Thousand Twenty One Term Note14.00%––
Two Thousand Twenty Three Term Note Payable–$1.00M$1.40M
Two Thousand Twenty Three Term Note Payable Two–$1.20M–
Two Thousand Twenty Two Term Note Payable–$200.00K–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?